PFIZER INC Other Short-term Investments
PFIZER INC (PFE) had Other Short-term Investments of $10.72 billion as of 2026-06-28, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:OtherShortTermInvestments · last filed 2026-08-04
- 2026-06-28: Other Short-term Investments $10.72B.
- 2026-03-29: Other Short-term Investments $11.37B.
- 2025-12-31: Other Short-term Investments $12.45B.
- 2025-09-28: Other Short-term Investments $13.64B.
| Period end | Other Short-term Investments |
|---|---|
| 2026-06-28 | $10.72B 10-Q · filed 2026-08-04 |
| 2026-03-29 | $11.37B 10-Q · filed 2026-05-05 |
| 2025-12-31 | $12.45B 10-Q · filed 2026-08-04 |
| 2025-09-28 | $13.64B 10-Q · filed 2025-11-04 |
| 2025-06-29 | $11.61B 10-Q · filed 2025-08-05 |
| 2025-03-30 | $15.89B 10-Q · filed 2025-05-05 |
| 2024-12-31 | $19.43B 10-K · filed 2026-02-26 |
| 2024-09-29 | $8.86B 10-Q · filed 2024-11-04 |
| 2024-06-30 | $6.05B 10-Q · filed 2024-08-05 |
| 2024-03-31 | $11.21B 10-Q · filed 2024-05-08 |
| 2023-12-31 | $9.84B 10-K · filed 2025-02-27 |
| 2023-10-01 | $41.03B 10-Q · filed 2023-11-08 |
| 2023-07-02 | $42.15B 10-Q · filed 2023-08-09 |
| 2023-04-02 | $17.81B 10-Q · filed 2023-05-10 |
| 2022-12-31 | $22.32B 10-K · filed 2024-02-22 |
| 2022-10-02 | $34.83B 10-Q · filed 2022-11-09 |
| 2022-07-03 | $31.52B 10-Q · filed 2022-08-10 |
| 2022-04-03 | $21.43B 10-Q · filed 2022-05-11 |
| 2021-12-31 | $29.13B 10-K · filed 2023-02-23 |
| 2021-10-03 | $27.73B 10-Q · filed 2021-11-12 |
| 2021-07-04 | $19.33B 10-Q · filed 2021-08-12 |
| 2021-04-04 | $11.90B 10-Q · filed 2021-05-13 |
| 2020-12-31 | $10.44B 10-K · filed 2022-02-24 |
| 2020-09-27 | $8.91B 10-Q · filed 2020-11-05 |
| 2020-06-28 | $9.58B 10-Q · filed 2020-08-06 |
| 2019-12-31 | $8.53B 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |